Page last updated: 2024-11-05

ethyl linoleate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

ethyl linoleate : A long-chain fatty acid ethyl ester resulting from the formal condensation of the carboxy group of linoleic acid with the hydroxy group of ethanol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5282184
CHEMBL ID2106238
CHEBI ID31572
SCHEMBL ID81540
MeSH IDM0051020

Synonyms (57)

Synonym
AKOS015843230
linoleic acid, ethyl ester
ethyl linolate
linoleic acid ethyl ester
9,z)-, ethyl ester
nsc50447
ethyl linoleate
ethyl cis,12-octadecadienoate
544-35-4
mandenol
nsc-50447
ethyl linoleate, >=99%
ethyl linoleate (jan)
D01590
ethyl linoleate, technical, >=65% (gc)
L0055
L0135
ethyl (9z,12z)-octadeca-9,12-dienoate
QSPL 206
9,12,octadececadienoic acid, ethyl ester
CHEMBL2106238
chebi:31572 ,
ethyl linoleate [jan]
9,12-octadecadienoic acid ethyl ester
ethyl linoleate, pure
nsc 50447
9,12-octadecadienoic acid (9z,12z)-, ethyl ester
einecs 208-868-4
ethyl cis,cis-9,12-octadecadienoate
mj2ytt4j8m ,
ec 208-868-4
unii-mj2ytt4j8m
9,12-octadecadienoic acid (z,z)-, ethyl ester
ethyl linoleate [usp-rs]
ethyl linoleate [who-dd]
ethyl linoleate [inci]
ethyl linoleate [mi]
ethyl (z,z)-9,12-octadecadienoate
SCHEMBL81540
ethyl (9z,12z)-9,12-octadecadienoate #
DTXSID1060269
ethyl (9z,12z)-octadecadienoate
AC-33781
HMS3650O09
mfcd00009535
ethyl linoleate, analytical standard
ethyl linoleate, united states pharmacopeia (usp) reference standard
AS-63462
cis-9,cis-12-octadecadienoic acid ethyl ester
Q27104200
SR-01000946817-1
sr-01000946817
D91254
fmoc-(s)-3-amino-3-(2-naphthyl)-propionicacid
CS-W014528
HY-W013812
ethyl linoleate (usp-rs)

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
") We suggest that Ethyl Linoleate agent (hELate) may be used safely in combination with selected antibacterial substances."( Studies in burns: XIV, Heling in burn wounds treated with Ethyl Linoleate alone or in combination with selected topical antibacterial agents.
Anderson, AP; Callaway, BD; Jelenko, C; McKinley, JC; Wheeler, ML, 1975
)
0.25

Bioavailability

ExcerptReferenceRelevance
" The results indicated that incorporation of antioxidants in this new SMEDDS not only significantly reduced ritonavir-induced ER stress activation, ROS production and apoptosis in intestinal epithelial cells and macrophages, but also improved the solubility, stability and bioavailability of ritonavir, and significantly reduced ritonavir-induced disruption of intestinal barrier function in vivo."( Development of a novel self-microemulsifying drug delivery system for reducing HIV protease inhibitor-induced intestinal epithelial barrier dysfunction.
Jin, F; Lei, B; Studer, EJ; Wang, G; Wang, X; Wang, Y; Wen, C; Zha, W; Zhang, L; Zhou, H, 2010
)
0.36

Dosage Studied

ExcerptRelevanceReference
" The oleate dosage served as control."( The effect of a single oral dose of ethyl linoleate on urinary prostaglandin E2 excretion in essential fatty acid-deficient rats.
Hansen, HS; Jensen, B, 1985
)
0.27
" 2"-O-GIV exhibited a dose-response effect but alpha-tocopherol did not."( Inhibitory effect of 2"-O-glycosyl isovitexin and alpha-tocopherol on genotoxic glyoxal formation in a lipid peroxidation system.
Hagiwara, H; Hagiwara, Y; Nishiyama, T; Shibamoto, T, 1994
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
anti-inflammatory agentAny compound that has anti-inflammatory effects.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
long-chain fatty acid ethyl esterA fatty acid ethyl ester resulting from the formal condensation of the carboxy group of a long-chain fatty acid with the hydroxy group of ethanol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (43)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (23.26)18.7374
1990's10 (23.26)18.2507
2000's12 (27.91)29.6817
2010's9 (20.93)24.3611
2020's2 (4.65)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (6.67%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (2.22%)4.05%
Observational1 (2.22%)0.25%
Other40 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]